Particle disease: Biologic mechanisms of periprosthetic osteolysis in total hip arthroplasty

Innate Immunity

Volumn 19, Issue 2, 2013, Pages 213-224

  Gallo, Jiri ^a   Goodman, Stuart B ^b   Konttinen, Yrjö T ^c   Raska, Milan ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

cytokines total hip arthroplasty; dendritic cells; fibroblasts; Homeostatic mechanisms; inflammatory response; lymphocytes; macrophages; osteoclasts; periprosthetic osteolysis; replacement; tissue appropriate response

Indexed keywords

ADVANCED GLYCATION END PRODUCT; COLONY STIMULATING FACTOR 1; CRYOPYRIN; CYCLOOXYGENASE 2; DNA; FIBROBLAST GROWTH FACTOR; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; NEUROTRANSMITTER; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPONTIN; OSTEOPROTEGERIN; PURINERGIC P2X7 RECEPTOR; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; ULTRA HIGH MOLECULAR WEIGHT POLYETHYLENE; UNINDEXED DRUG; VASCULOTROPIN;

ALLELE; BONE ATROPHY; BONE IMPLANT; CELL DIFFERENTIATION; CELL PROLIFERATION; DENDRITIC CELL; DISEASE SEVERITY; DNA DAMAGE; DNA SEQUENCE; FIBROBLAST; FOREIGN BODY REACTION; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE; OSSIFICATION; OSTEOCLAST; PARTICLE DISEASE; PERIPROSTHETIC OSTEOLYSIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STEM CELL; TH1 CELL; TH17 CELL; TISSUE STRUCTURE; TOTAL HIP PROSTHESIS;

ANIMALS; ARTHROPLASTY, REPLACEMENT, HIP; CELLULAR MICROENVIRONMENT; HAJDU-CHENEY SYNDROME; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; JOINT PROSTHESIS; OSTEOGENESIS; PROSTHESIS FAILURE;

EID: 84876365875     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425912451779     Document Type: Review

References (81)

1. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007 ; 89: 780-785
2. Ulrich SD, Seyler TM, Bennett D, Delanois RE, Saleh KJ, Thongtrangan I, et al. Total hip arthroplasties: What are the reasons for revision?. Int Orthop. 2008 ; 32: 597-604
3. Gallo J, Kaminek P, Zapletalova J, Cechova I, Spicka J, Ditmar R. Is osteolysis associated with a stable total hip replacement asymptomatic?. Acta Chir Orthop Traumatol Cech. 2004 ; 71: 20-25
4. Maloney W, Rosenberg A. What is the outcome of treatment for osteolysis?. J Am Acad Orthop Surg. 2008 ; 16 (Suppl. 1): S26 - S32
5. Deirmengian GK, Zmistowski B, O'Neil JT, Hozack WJ. Management of acetabular bone loss in revision total hip arthroplasty. J Bone Joint Surg Am. 2011 ; 93: 1842-1852
6. Garcia-Cimbrelo E, Garcia-Rey E, Cruz-Pardos A. The extent of the bone defect affects the outcome of femoral reconstruction in revision surgery with impacted bone grafting: a five- to 17-year follow-up study. J Bone Joint Surg Br. 2011 ; 93: 1457-1464
7. Dumbleton JH, Manley MT, Edidin AA. A literature review of the association between wear rate and osteolysis in total hip arthroplasty. J Arthroplasty. 2002 ; 17: 649-661
8. Kurtz SM, Gawel HA, Patel JD. History and systematic review of wear and osteolysis outcomes for first-generation highly crosslinked polyethylene. Clin Orthop Relat Res. 2011 ; 469: 2262-2277
9. Gallo J, Slouf M, Goodman SB. The relationship of polyethylene wear to particle size, distribution, and number: A possible factor explaining the risk of osteolysis after hip arthroplasty. J Biomed Mater Res B Appl Biomater. 2010 ; 94: 171-177
10. Aspenberg P, van der Vis H. Fluid pressure may cause periprosthetic osteolysis. Particles are not the only thing. Acta Orthop Scand. 1998 ; 69: 1-4
11. Willert HG, Semlitsch M. Reactions of the articular capsule to wear products of artificial joint prostheses. J Biomed Mater Res. 1977 ; 11: 157-164
12. Maloney WJ, Jasty M, Harris WH, Galante JO, Callaghan JJ. Endosteal erosion in association with stable uncemented femoral components. J Bone Joint Surg Am. 1990 ; 72: 1025-1034
13. Goodman SB, Chin RC, Chiou SS, Schurman DJ, Woolson ST and Masada MP. A clinical-pathologic-biochemical study of the membrane surrounding loosened and nonloosened total hip arthroplasties. Clin Orthop Relat Res 1989;Jul: 182-187.
14. Tallroth K, Eskola A, Santavirta S, Konttinen YT, Lindholm TS. Aggressive granulomatous lesions after hip arthroplasty. J Bone Joint Surg Br. 1989 ; 71: 571-575
15. Santavirta S, Konttinen YT, Bergroth V, Eskola A, Tallroth K, Lindholm TS. Aggressive granulomatous lesions associated with hip arthroplasty. Immunopathological studies. J Bone Joint Surg Am. 1990 ; 72: 252-258
16. Harris WH. Osteolysis and particle disease in hip replacement. A review. Acta Orthop Scand. 1994 ; 65: 113-123
17. Konttinen YT, Zhao D, Beklen A, Ma G, Takagi M, Kivela-Rajamaki M, et al. The microenvironment around total hip replacement prostheses. Clin Orthop Relat Res 2005 Jan: 28-38.
18. Ren PG, Irani A, Huang Z, Ma T, Biswal S, Goodman SB. Continuous infusion of UHMWPE particles induces increased bone macrophages and osteolysis. Clin Orthop Relat Res. 2011 ; 469: 113-122
19. Gallo J, Raska M, Mrazek F, Petrek M. Bone remodeling, particle disease and individual susceptibility to periprosthetic osteolysis. Physiol Res. 2008 ; 57: 339-349
20. Schmalzried TP, Jasty M, Harris WH. Periprosthetic bone loss in total hip arthroplasty. Polyethylene wear debris and the concept of the effective joint space. J Bone Joint Surg Am. 1992 ; 74: 849-863
21. Gallo J, Havranek V, Cechova I, Zapletalova J. Influence of demographic, surgical and implant variables on wear rate and osteolysis in ABG I hip arthroplasty. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2006 ; 150: 135-141
22. Engh CA, Hooten JP, Zettl-Schaffer KF, Ghaffarpour M, McGovern TF, Bobyn JD. Evaluation of bone ingrowth in proximally and extensively porous-coated anatomic medullary locking prostheses retrieved at autopsy. J Bone Joint Surg Am. 1995 ; 77: 903-910
23. Wilkinson JM, Wilson AG, Stockley I, Scott IR, Macdonald DA, Hamer AJ, et al. Variation in the TNF gene promoter and risk of osteolysis after total hip arthroplasty. J Bone Miner Res. 2003 ; 18: 1995-2001
24. Gallo J, Mrazek F, Petrek M. Variation in cytokine genes can contribute to severity of acetabular osteolysis and risk for revision in patients with ABG 1 total hip arthroplasty: a genetic association study. BMC Med Genet. 2009 ; 10: 109-109
25. Gordon A, Kiss-Toth E, Stockley I, Eastell R, Wilkinson JM. Polymorphisms in the interleukin-1 receptor antagonist and interleukin-6 genes affect risk of osteolysis in patients with total hip arthroplasty. Arthritis Rheum. 2008 ; 58: 3157-3165
26. Mrazek F, Gallo J, Stahelova A, Petrek M. Functional variants of the P2RX7 gene, aseptic osteolysis, and revision of the total hip arthroplasty: a preliminary study. Hum Immunol. 2010 ; 71: 201-205
27. Del Buono A, Denaro V, Maffulli N. Genetic susceptibility to aseptic loosening following total hip arthroplasty: a systematic review. Br Med Bull. 2012 ; 101: 39-55
28. Fornasier V, Wright J, Seligman J. The histomorphologic and morphometric study of asymptomatic hip arthroplasty. A postmortem study. Clin Orthop Relat Res. 1991 ; 271: 272-282
29. Kwong LM, Jasty M, Mulroy RD, Maloney WJ, Bragdon C, Harris WH. The histology of the radiolucent line. J Bone Joint Surg Br. 1992 ; 74: 67-73
30. Skurla CP, James SP. Assessing the dog as a model for human total hip replacement: analysis of 38 postmortem-retrieved canine cemented acetabular components. J Biomed Mater Res B Appl Biomater. 2005 ; 73: 260-270
31. Ma T, Ortiz SG, Huang Z, Ren P, Smith RL, Goodman SB. In vivo murine model of continuous intramedullary infusion of particles-a preliminary study. J Biomed Mater Res B Appl Biomater. 2009 ; 88: 250-253
32. El-Warrak AO, Olmstead M, Schneider R, Meinel L, Bettschart-Wolfisberger R, Akens MK, et al. An experimental animal model of aseptic loosening of hip prostheses in sheep to study early biochemical changes at the interface membrane. BMC Musculoskelet Disord. 2004 ; 5: 7-7
33. Shanbhag AS, Kaufman AM, Hayata K, Rubash HE. Assessing osteolysis with use of high-throughput protein chips. J Bone Joint Surg Am. 2007 ; 89: 1081-1089
34. Anderson JM. Biological responses to materials. Annu Rev Mater Res. 2001 ; 31: 81-110
35. Cooper HJ, Ranawat AS, Potter HG, Foo LF, Koob TW, Ranawat CS. Early reactive synovitis and osteolysis after total hip arthroplasty. Clin Orthop Relat Res. 2010 ; 468: 3278-3285
36. Aspenberg P, Wagner P, Nilsson KG, Ranstam J. Fixed or loose? Dichotomy in RSA data for cemented cups. Acta Orthop. 2008 ; 79: 467-473
37. Medzhitov R. Inflammation 2010: new adventures of an old flame. Cell. 2010 ; 140: 771-776
38. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol. 1994 ; 12: 991-1045
39. Nakashima T, Hayashi M, Fukunaga T, Kurata K, Oh-Hora M, Feng JQ, et al. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med. 2011 ; 17: 1231-1234
40. Konttinen Y, Imai S, Suda A. Neuropeptides and the puzzle of bone remodeling. State of the art. Acta Orthop Scand. 1996 ; 67: 632-639
41. King KY, Goodell MA. Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response. Nat Rev Immunol. 2011 ; 11: 685-692
42. Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol. 2011 ; 11: 723-737
43. Buckley CD. Why does chronic inflammation persist: An unexpected role for fibroblasts. Immunol Lett. 2011 ; 138: 12-14
44. Nathan C, Ding A. Nonresolving inflammation. Cell. 2010 ; 140: 871-882
45. Perez-Losada J, Balmain A. Stem-cell hierarchy in skin cancer. Nat Rev Cancer. 2003 ; 3: 434-443
46. Zlotnik A, Burkhardt AM, Homey B. Homeostatic chemokine receptors and organ-specific metastasis. Nat Rev Immunol. 2011 ; 11: 597-606
47. O'Connell RM, Rao DS, Baltimore D. microRNA regulation of inflammatory responses. Annu Rev Immunol. 2012 ; 30: 295-312
48. Karouzakis E, Gay RE, Gay S, Neidhart M. Epigenetic control in rheumatoid arthritis synovial fibroblasts. Nat Rev Rheumatol. 2009 ; 5: 266-272
49. Goodman SB, Ma T. Cellular chemotaxis induced by wear particles from joint replacements. Biomaterials. 2010 ; 31: 5045-5050
50. Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol. 2008 ; 20: 86-100
51. Anttila A, Lappalainen R, Heinonen H, Santavirta S, Konttinen YT. Superiority of diamondlike carbon coating on articulating surfaces of artificial hip joints. New Diamond Frontier Carbon Technol. 1999 ; 9: 283-288
52. Callaghan JJ, Cuckler JM, Huddleston JI, Galante JO. How have alternative bearings (such as metal-on-metal, highly cross-linked polyethylene, and ceramic-on-ceramic) affected the prevention and treatment of osteolysis?. J Am Acad Orthop Surg. 2008 ; 16 (Suppl. 1). S33 - S38
53. Catelas I, Jacobs JJ. Biologic activity of wear particles. Instr Course Lect. 2010 ; 59: 3-16
54. Landgraeber S, Jaeckel S, Loer F, Wedemeyer C, Hilken G, Canbay A, et al. Pan-caspase inhibition suppresses polyethylene particle-induced osteolysis. Apoptosis. 2009 ; 14: 173-181
55. Santavirta S, Takagi M, Gomez-Barrena E, Nevalainen J, Lassus J, Salo J, et al. Studies of host response to orthopedic implants and biomaterials. J Long Term Eff Med Implants. 1999 ; 9: 67-76
56. Hubbi ME, Luo W, Baek JH, Semenza GL. MCM proteins are negative regulators of hypoxia-inducible factor 1. Mol Cell. 2011 ; 42: 700-712
57. Knowles HJ, Athanasou NA. Acute hypoxia and osteoclast activity: a balance between enhanced resorption and increased apoptosis. J Pathol. 2009 ; 218: 256-264
58. Waris V, Sillat T, Waris E, Virkki L, Mandelin J, Takagi M, et al. Role and regulation of VEGF and its receptors 1 and 2 in the aseptic loosening of total hip implants. J Orthop Res. Epub ahead of print 23 April 2012. DOI: 10.1002/jor.22138.
59. Gross TS, King KA, Rabaia NA, Pathare P, Srinivasan S. Upregulation of osteopontin by osteocytes deprived of mechanical loading or oxygen. J Bone Miner Res. 2005 ; 20: 250-256
60. Seong SY, Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol. 2004 ; 4: 469-478
61. Janeway CA. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol. 1989 ; 54: 1-13
62. Oppenheim JJ, Yang D. Alarmins: chemotactic activators of immune responses. Curr Opin Immunol. 2005 ; 17: 359-365
63. Greenfield EM, Beidelschies MA, Tatro JM, Goldberg VM, Hise AG. Bacterial pathogen-associated molecular patterns stimulate biological activity of orthopaedic wear particles by activating cognate Toll-like receptors. J Biol Chem. 2010 ; 285: 32378-32384
64. Pearl JI, Ma T, Irani AR, Huang Z, Robinson WH, Smith RL, et al. Role of the Toll-like receptor pathway in the recognition of orthopedic implant wear-debris particles. Biomaterials. 2011 ; 32: 5535-5542
65. Takagi M, Tamaki Y, Hasegawa H, Takakubo Y, Konttinen L, Tiainen VM, et al. Toll-like receptors in the interface membrane around loosening total hip replacement implants. J Biomed Mater Res A. 2007 ; 81: 1017-1026
66. Maitra R, Clement CC, Scharf B, Crisi GM, Chitta S, Paget D, et al. Endosomal damage and TLR2 mediated inflammasome activation by alkane particles in the generation of aseptic osteolysis. Mol Immunol. 2009 ; 47: 175-184
67. Medzhitov R, Shevach EM, Trinchieri G, Mellor AL, Munn DH, Gordon S, et al. Highlights of 10 years of immunology in Nature Reviews Immunology. Nat Rev Immunol. 2011 ; 11: 693-702
68. Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008 ; 454: 428-435
69. Fujii J, Yasunaga Y, Yamasaki A and Ochi M. Wear debris stimulates bone-resorbing factor expression in the fibroblasts and osteoblasts. Hip Int. Epub ahead of print 11 April 2011. DOI: 511AE461-986F-4E4E-91C3-C511BBA83406.
70. Garrigues GE, Cho DR, Rubash HE, Goldring SR, Herndon JH, Shanbhag AS. Gene expression clustering using self-organizing maps: analysis of the macrophage response to particulate biomaterials. Biomaterials. 2005 ; 26: 2933-2945
71. Grom AA, Mellins ED. Macrophage activation syndrome: advances towards understanding pathogenesis. Curr Opin Rheumatol. 2010 ; 22: 561-566
72. Zhang Y, Hou C, Yu S, Xiao J, Zhang Z, Zhai Q, et al. IRAK-M in macrophages around septically and aseptically loosened hip implants. J Biomed Mater Res A. 2012 ; 100: 261-268
73. Liddiard K, Rosas M, Davies LC, Jones SA, Taylor PR. Macrophage heterogeneity and acute inflammation. Eur J Immunol. 2011 ; 41: 2503-2508
74. Matzinger P, Kamala T. Tissue-based class control: the other side of tolerance. Nat Rev Immunol. 2011 ; 11: 221-230
75. Ma J, Chen T, Mandelin J, Ceponis A, Miller NE, Hukkanen M, et al. Regulation of macrophage activation. Cell Mol Life Sci. 2003 ; 60: 2334-2346
76. Valledor AF, Comalada M, Santamaria-Babi LF, Lloberas J, Celada A. Macrophage proinflammatory activation and deactivation: a question of balance. Adv Immunol. 2010 ; 108: 1-20
77. Huss RS, Huddleston JI, Goodman SB, Butcher EC, Zabel BA. Synovial tissue-infiltrating natural killer cells in osteoarthritis and periprosthetic inflammation. Arthritis Rheum. 2010 ; 62: 3799-3805
78. Koreny T, Tunyogi-Csapo M, Gal I, Vermes C, Jacobs JJ, Glant TT. The role of fibroblasts and fibroblast-derived factors in periprosthetic osteolysis. Arthritis Rheum. 2006 ; 54: 3221-3232
79. Josefowicz SZ, Lu LF, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol. 2012 ; 30: 531-564
80. Thyssen JP, Jakobsen SS, Engkilde K, Johansen JD, Soballe K, Menne T. The association between metal allergy, total hip arthroplasty, and revision. Acta Orthop. 2009 ; 80: 646-652
81. Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CG, Doering TA, et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol. 2011 ; 12: 1045-1054